Showing results (1511-1520 of 1,605) with videos related to
Sort By:
Pageof 161
Lung Cancer (Amsterdam, Netherlands)|June 26, 2026
Durvalumab plus etoposide-platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARDIsamu Okamoto, Byoung Chul Cho, Sarah B Goldberg, et al.Biorxiv : the Preprint Server for Biology|September 10, 2020
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19Miguel Reyes, Michael R Filbin, Roby P Bhattacharyya, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNASarah B Goldberg, Azeet Narayan, Adam J Kole, et al.The Lancet. Oncology|June 9, 2016
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialSarah B Goldberg, Scott N Gettinger, Amit Mahajan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast CancerSakar Wahby, Lola Fashoyin-Aje, Christy L Osgood, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.Science Translational Medicine|June 9, 2021
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitroMiguel Reyes, Michael R Filbin, Roby P Bhattacharyya, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and RecommendationsJordi Remon, Francesco Passiglia, Myung-Ju Ahn, et al.Clinical Lung Cancer|August 14, 2021
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)Helena A Yu, Sarah B Goldberg, Xiuning Le, et al.Diabetes|May 17, 2024
Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With PrediabetesLiana K Billings, Kathleen A Jablonski, Qing Pan, et al.Pageof 161